Jeffrey W Moses

Summary

Affiliation: Lenox Hill Hospital
Country: USA

Publications

  1. ncbi request reprint Perspectives of drug-eluting stents: the next revolution
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiovasc Drugs 2:163-72. 2002
  2. ncbi request reprint Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiol 90:243-7. 2002
  3. ncbi request reprint Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Jeffrey W Moses
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute of New York, New York 10021, USA
    N Engl J Med 349:1315-23. 2003
  4. ncbi request reprint Brachytherapy and drug-eluting stents
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute, 130 East 77th Street, 9th Floor, New York, NY 10021, USA
    J Invasive Cardiol 15:30B-32B; discussion 32B-33B. 2003
  5. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009
  6. doi request reprint Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:748-57. 2009
  7. pmc The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience
    Philip Green
    Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA
    JACC Cardiovasc Interv 5:974-81. 2012
  8. ncbi request reprint Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Catheter Cardiovasc Interv 64:389-94. 2005
  9. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
  10. ncbi request reprint Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 61:518-27. 2004

Detail Information

Publications112 found, 100 shown here

  1. ncbi request reprint Perspectives of drug-eluting stents: the next revolution
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiovasc Drugs 2:163-72. 2002
    ..The prospect of approval of this technology should herald a host of clinical trials to revisit basic assumptions about the place of coronary stenting in the contemporary care of obstructive (and nonobstructive) CAD...
  2. ncbi request reprint Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiol 90:243-7. 2002
    ..The relative impact of this treatment is more pronounced in diabetic patients because it appears to neutralize the added risk of recurrent restenosis seen in proliferative diabetic lesions...
  3. ncbi request reprint Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Jeffrey W Moses
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute of New York, New York 10021, USA
    N Engl J Med 349:1315-23. 2003
    ..Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization...
  4. ncbi request reprint Brachytherapy and drug-eluting stents
    Jeffrey W Moses
    Lenox Hill Heart and Vascular Institute, 130 East 77th Street, 9th Floor, New York, NY 10021, USA
    J Invasive Cardiol 15:30B-32B; discussion 32B-33B. 2003
  5. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009
    ..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
  6. doi request reprint Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:748-57. 2009
    ....
  7. pmc The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience
    Philip Green
    Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA
    JACC Cardiovasc Interv 5:974-81. 2012
    ..This study sought to evaluate the impact of frailty in older adults undergoing transcatheter aortic valve replacement (TAVR) for symptomatic aortic stenosis...
  8. ncbi request reprint Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Catheter Cardiovasc Interv 64:389-94. 2005
    ..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
  9. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
    ..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
  10. ncbi request reprint Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 61:518-27. 2004
    ..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
  11. doi request reprint Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions
    Kenichi Tsujita
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    JACC Cardiovasc Interv 2:846-54. 2009
    ..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
  12. ncbi request reprint Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Lancet 369:907-19. 2007
    ..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
  13. ncbi request reprint Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    JAMA 298:2497-506. 2007
    ....
  14. ncbi request reprint Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound
    Masashi Kimura
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:436-42. 2006
    ..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
  15. ncbi request reprint Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:355-9. 2005
    ..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
  16. ncbi request reprint Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 110:3430-4. 2004
    ..Little is known about causes of intimal hyperplasia (IH) after sirolimus-eluting stent (SES) implantation...
  17. doi request reprint Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
    Young Hak Kim
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 101:801-6. 2008
    ..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
  18. doi request reprint Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
    Bimmer E Claessen
    Cardiovascular Research Foundation, Clinical Trial Center, New York, New York, USA
    JACC Cardiovasc Interv 4:974-81. 2011
    ..This study sought to assess the impact of intravascular ultrasound (IVUS)-guided versus angiography-guided drug-eluting stent (DES) implantation...
  19. doi request reprint Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation
    Xuebo Liu
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 2:997-1004. 2009
    ..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
  20. ncbi request reprint Frequency and determinants of black holes in sirolimus-eluting stent restenosis
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    J Invasive Cardiol 18:348-52. 2006
    ..We sought to investigate the frequency and determinants of black holes (BH) after sirolimus-eluting stent (SES) implantation...
  21. ncbi request reprint Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 95:498-502. 2005
    ....
  22. ncbi request reprint Intravascular ultrasound assessment of drug-eluting stent expansion
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, NY, USA
    Am Heart J 153:297-303. 2007
    ....
  23. ncbi request reprint Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)
    Yoshihiro Tsuchiya
    The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 98:464-9. 2006
    ..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
  24. pmc Patient radiation exposure during transcatheter aortic valve replacement procedures
    Benoit Daneault
    Columbia University Medical Center New York Presbyterian Hospital, New York, NY 10032, USA
    EuroIntervention 8:679-84. 2012
    ..To describe patient radiation utilisation during transcatheter aortic valve replacement (TAVR) on a series of consecutive patients...
  25. ncbi request reprint Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 98:1559-62. 2006
    ....
  26. doi request reprint Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
  27. ncbi request reprint Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy)
    Giora Weisz
    Columbia University Medical Center, and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 99:1044-50. 2007
    ..Patients with unstable angina undergoing percutaneous coronary intervention who meet the entry criteria of the SIRIUS study should be preferentially treated with SESs...
  28. ncbi request reprint Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1171-6. 2003
    ..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
  29. doi request reprint Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, New York 10029, USA
    Catheter Cardiovasc Interv 82:76-82. 2013
    ..This study sought to investigate whether there is a differential prognostic effect of successful percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) according to the target vessel the CTO is located in...
  30. doi request reprint Virtual histology intravascular ultrasound comparison of coronary chronic total occlusions versus non-occlusive lesions
    Jun Guo
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Int J Cardiovasc Imaging 29:1249-54. 2013
    ..5 %, p = 0.022) at maximum necrotic core site. These findings suggest that the morphological characteristics of most CTOs were similar as compared with non-CTO lesions and CTOs evolved from fibroatheromas...
  31. ncbi request reprint Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study
    Kenichi Fujii
    Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
    J Am Coll Cardiol 45:995-8. 2005
    ..We sought to determine the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation...
  32. ncbi request reprint Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention
    Eugenia Nikolsky
    Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 94:300-5. 2004
    ..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
  33. doi request reprint Transcatheter versus surgical aortic-valve replacement in high-risk patients
    Craig R Smith
    Columbia University Medical Center New York Presbyterian Hospital, New York, NY 10032, USA
    N Engl J Med 364:2187-98. 2011
    ..However, the two procedures have not been compared in a randomized trial involving high-risk patients who are still candidates for surgical replacement...
  34. pmc High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study
    Amala P Chirumamilla
    Albert Einstein College of Medicine, New York, New York, USA
    JACC Cardiovasc Imaging 5:540-9. 2012
    ..This study sought to evaluate the relationship between platelet reactivity and atherosclerotic burden in patients undergoing percutaneous coronary intervention (PCI) with pre-intervention volumetric intravascular ultrasound (IVUS) imaging...
  35. doi request reprint Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials
    Ajay J Kirtane
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 51:708-15. 2008
    ..We sought to examine the safety and efficacy of paclitaxel-eluting stents (PES) in patients with diabetes mellitus (DM)...
  36. ncbi request reprint Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 356:998-1008. 2007
    ..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
  37. doi request reprint Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
    Eduardo Missel
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:573-8. 2008
    ..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
  38. doi request reprint 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents
    Adriano Caixeta
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 54:894-902. 2009
    ..Five-year clinical follow-up has been scheduled per protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) versus bare-metal stent (BMS) randomized trials...
  39. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003
    ..We sought to determine the impact of aggressive stent expansion on creatine kinase-MB isoenzyme (CK-MB) release and clinical restenosis...
  40. doi request reprint Long-term outcome of percutaneous coronary intervention for chronic total occlusions
    Roxana Mehran
    Mount Sinai Medical Center and the Cardiovascular Research Foundation, New York, New York 10029, USA
    JACC Cardiovasc Interv 4:952-61. 2011
    ..The aim of this study was to evaluate long-term clinical outcomes after percutaneous coronary intervention (PCI) for chronic total occlusions (CTO)...
  41. ncbi request reprint Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am J Cardiol 93:1536-9. 2004
    ..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
  42. doi request reprint Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial)
    Susheel K Kodali
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 107:1058-64. 2011
    ..Procedural complications and late major adverse cardiac and cerebrovascular events, however, overshadowed the overall clinical benefit of TAVI in this high-risk patient population...
  43. ncbi request reprint Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 97:1463-6. 2006
    ..These IVUS differences may account for some of the location-specific differences in interventional complications...
  44. ncbi request reprint Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:370-4. 2006
    ..The CSG may be a reliable and highly effective treatment option for sealing coronary perforations complicating percutaneous coronary interventions...
  45. ncbi request reprint Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
    Jiro Aoki
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:58-62. 2008
    ..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
  46. ncbi request reprint Short- and long-term results after multivessel stenting in diabetic patients
    Roxana Mehran
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 43:1348-54. 2004
    ..The present study evaluated clinical outcomes in diabetic patients after multivessel stenting...
  47. ncbi request reprint Bivalirudin for patients with acute coronary syndromes
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 355:2203-16. 2006
    ..We evaluated the role of thrombin-specific anticoagulation with bivalirudin in such patients...
  48. ncbi request reprint The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention
    Adam J Saltzman
    Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
    J Invasive Cardiol 22:2-6. 2010
    ..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
  49. doi request reprint Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 59:1752-9. 2012
    ....
  50. ncbi request reprint Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 100:812-7. 2007
    ..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
  51. ncbi request reprint Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques
    Kenichi Fujii
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 96:352-7. 2005
    ..In conclusion, ruptured plaques are associated with a larger number of calcium deposits within an arc of <90 degrees , a larger number of deep calcium deposits, and a remodeling index...
  52. ncbi request reprint Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials
    Somjot S Brar
    Columbia University Medical Center, New York, NY, USA
    EuroIntervention 5:475-84. 2009
    ....
  53. ncbi request reprint A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
    Roxana Mehran
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 44:1393-9. 2004
    ..We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)...
  54. ncbi request reprint Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis
    Kazuyuki Shirai
    Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 92:1409-13. 2003
    ..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
  55. doi request reprint Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial
    Giora Weisz
    Center for Interventional Vascular Therapy, New York Presbyterian Hospital, Columbia University, and Cardiovascular Research Foundation, New York, USA
    J Am Coll Cardiol 53:1488-97. 2009
    ..The aim of this study was to examine the 5-year clinical safety and efficacy outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial...
  56. ncbi request reprint Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
    Circulation 109:1085-8. 2004
    ..We used intravascular ultrasound (IVUS) to evaluate recurrence after sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR)...
  57. ncbi request reprint Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 46:599-605. 2005
    ..We report intravascular ultrasound (IVUS) findings after crush-stenting of bifurcation lesions...
  58. ncbi request reprint Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    JAMA 297:591-602. 2007
    ..The preferred approach is undetermined...
  59. ncbi request reprint Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Catheter Cardiovasc Interv 60:496-9. 2003
    ..This case report describes in-stent restenosis due to stent underexpansion after kissing stents using sirolimus-eluting stents...
  60. ncbi request reprint The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems
    Kaoru Tanaka
    Clinical Medicine, Intravascular Imaging and Physiology Core Laboratory, Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, 6th Floor, New York, NY, USA
    Int J Cardiovasc Imaging 23:733-8. 2007
    ..5 +/- 31.4% to 9.7 +/- 8.3%. Thus, there is a significant variation in length measurement accuracy among IVUS pullback devices. This should be taken into account both clinically and when planning scientific studies...
  61. ncbi request reprint The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial)
    Issam D Moussa
    Columbia University Medical Center New York Presbyterian Hospital and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 97:1582-4. 2006
    ..Future studies should evaluate other methods, including drug-eluting stents, to further optimize the outcome of treatment of SES failures...
  62. doi request reprint Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
    Adriano Caixeta
    Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 161:298-306.e1. 2011
    ..The aim of the study was to investigate the incidence and clinical consequences of acquired thrombocytopenia in patients with acute coronary syndromes (ACS) in the ACUITY trial...
  63. ncbi request reprint Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:659-63. 2005
    ..Thus, use of bivalirudin as the procedural anticoagulant to support SES implantation in a "real world" population of patients undergoing PCI results in low rates of major adverse cardiac events, stent thrombosis, and major bleeding...
  64. doi request reprint Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation
    Philippe Genereux
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 4:861-7. 2011
    ....
  65. ncbi request reprint Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 93:963-8. 2004
    ..A less aggressive stent implantation strategy in SVGs than in native coronary lesions appears prudent...
  66. ncbi request reprint Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling
    Kenichi Fujii
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:1476-83. 2005
    ..26, p=0.02). In conclusion, in vivo IVUS radiofrequency data analysis demonstrates that positive remodeling occurs in lesions with more fibrofatty plaque...
  67. ncbi request reprint Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial
    Giora Weisz
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 47:1350-5. 2006
    ..The purpose of this study was to examine the two-year clinical outcomes in patients enrolled in the Sirolimus-Eluting Stent in De Novo Native Coronary Lesions (SIRIUS) study...
  68. ncbi request reprint Intravascular ultrasound profile analysis of ruptured coronary plaques
    Kenichi Fujii
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:429-35. 2006
    ..Rather, vulnerable (rupture-prone) plaques predictably have significant plaque accumulation and remodeling and occur in larger arteries. It is only the degree of lumen compromise that is variable and often insignificant...
  69. ncbi request reprint Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
    Makoto Hirose
    Cardiovascular Research Foundation, New York, NY 10021, USA
    Am J Cardiol 92:141-5. 2003
    ..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
  70. ncbi request reprint Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model
    Gishel New
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 57:266-71. 2002
    ..Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis...
  71. ncbi request reprint Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 105:2347-54. 2002
    ..Also unknown is whether the acuity of the presenting clinical syndrome, which may affect the degree of platelet inhibition required or achieved, influences the response to different antiplatelet agents...
  72. ncbi request reprint New percutaneous approaches for chronic total occlusion of coronary arteries
    Giora Weisz
    Columbia University Medical Center, Center for Interventional Vascular Therapy, 161 Fort Washington Avenue, IP 5 Floor, New York, NY 10032, USA
    Expert Rev Cardiovasc Ther 5:231-41. 2007
    ..The success rates for otherwise refractory CTOs will continue to improve with the development and validation of new imaging modalities and active energy source catheters...
  73. ncbi request reprint The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions
    Jeffrey W Moses
    New York Presbyterian Hospital, Columbia University and Cardiovascular Research Foundation, New York, USA
    Catheter Cardiovasc Interv 70:505-12. 2007
    ..To assess the safety and efficacy of direct stenting using the sirolimus-eluting BX Velocitytrade mark stent in patients with coronary lesions...
  74. ncbi request reprint Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study)
    S Chiu Wong
    Weill Medical College of Cornell University, New York, New York 10021, USA
    Am J Cardiol 95:1043-8. 2005
    ..86, p = 0.76, and hazard ratio 0.58, p = 0.21, respectively). These data do not support the arbitrary use of larger ratios of stent length to lesion length in patients who undergo implantation of drug-eluting stents...
  75. ncbi request reprint Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial
    Jeffrey W Moses
    Columbia University Medical Center, New York, New York, USA
    J Am Coll Cardiol 45:1165-71. 2005
    ..We sought to investigate the outcomes of paclitaxel-eluting stent implantation in patients with unstable angina or non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (PCI)...
  76. ncbi request reprint A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique"
    Issam Moussa
    Cardiovascular Research Foundation and New York Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 97:1317-21. 2006
    ..Nonetheless, despite the excellent patency rates of the main vessel, the need for revascularization at the ostium of the side branch was not fully eliminated...
  77. ncbi request reprint Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions
    Yi ming Yang
    Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
    Catheter Cardiovasc Interv 63:462-8. 2004
    ..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
  78. ncbi request reprint Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    J Am Coll Cardiol 39:1686-91. 2002
    ..We evaluated the long-term influence of intramural delivery of advanced c-myc neutrally charged antisense oligonucleotides (Resten-NG) on neointimal hyperplasia after stenting in a pig model...
  79. doi request reprint Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion
    Yong He
    Cardiovascular Research Foundation, Columbia University Medical Center New York Presbyterian Hospital, New York, NY, USA
    Am J Cardiol 105:1272-5. 2010
    ..In conclusion, the acute performance of Xience/Promus was similar to that of previous stainless steel stents, and the thinner cobalt chromium metallic platform did not compromise the radial strength of the stent...
  80. ncbi request reprint Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy
    Issam Moussa
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 130 East 77th St, 9th Floor, New York, NY 10021, USA
    Circulation 109:2273-8. 2004
    ..The purpose of this analysis was to determine the impact of sirolimus-eluting stents on outcomes of diabetic compared with nondiabetic patients...
  81. ncbi request reprint Update on drug-eluting coronary stents
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Expert Rev Cardiovasc Ther 3:953-68. 2005
    ..Recent advances in vascular gene transfer have also demonstrated potential new treatment modalities for cardiovascular disease, particularly in the treatment of vascular restenosis...
  82. ncbi request reprint Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 130 East 77th Street, Black Hall, 9th Floor, New York, NY 10021, USA
    Cardiovasc Radiat Med 4:152-9. 2003
    ..The purpose of this study was to investigate the effects of perfluorocarbon gas microbubble carrier (PGMC)-based systemic delivery of AVI-4126 on expression of the c-myc in vascular tissue and restenosis after stent implantation...
  83. ncbi request reprint Enhanced long-term antiplatelet therapy after coronary stenting
    Jeffrey W Moses
    Columbia University Medical Center, New York, New York, USA
    J Invasive Cardiol 17:669-76. 2005
  84. ncbi request reprint Multiple ulcerations in plaque behind stent struts resulting in late stent malapposition after gamma brachytherapy for in-stent restenosis
    Makoto Hirose
    Cardiovascular Research Foundation, Lenox Hill Heart, New York, NY, USA
    J Invasive Cardiol 15:530-2. 2003
    ..This case report describes multiple ulcerations in plaque behind stent struts, resulting in multiple late stent malappositions, after intracoronary gamma brachytherapy for in-stent restenosis...
  85. ncbi request reprint Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old
    Yoshio Kobayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:443-6. 2003
    ....
  86. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004
    ..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
  87. ncbi request reprint Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial
    Jeffrey W Moses
    The Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:1455-60. 2006
    ..6%. In conclusion, use of the 2.25-mm sirolimus-eluting Bx Velocity stent was safe and provided favorable 6-month clinical outcomes. Use of multiple stents (in longer lesions) was an independent predictor of in-lesion restenosis...
  88. ncbi request reprint Assessing intermediate left main coronary lesions using intravascular ultrasound
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 154:983-8. 2007
    ..We aimed to evaluate the severity of ambiguous LMCSs by intravascular ultrasound (IVUS) and to clarify how frequently significant stenosis occurs in the "real world"...
  89. ncbi request reprint Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
    Thosaphol Limpijankit
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 92:315-8. 2003
    ..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
  90. ncbi request reprint Is the end of restenosis the beginning of a new era?
    Jeffrey W Moses
    Ital Heart J 5:81-4. 2004
  91. ncbi request reprint Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions
    Antonio Colombo
    EMO Centro Cuore Columbus, Milan, Italy
    Circulation 109:1244-9. 2004
    ..A sirolimus-eluting stent (Cypher, Cordis Corp) has been reported to markedly decrease restenosis in selected lesions; higher-risk lesions, including coronary bifurcations, have not been studied...
  92. ncbi request reprint Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial
    Shinjo Sonoda
    Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, California 94305 5637, USA
    J Am Coll Cardiol 43:1959-63. 2004
    ..We assessed the predictive value of minimum stent area (MSA) for long-term patency of sirolimus-eluting stents (SES) implantation compared to bare metal stents (BMS)...
  93. ncbi request reprint Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents
    Neil Sawhney
    Division of Cardiology, Scripps Clinic, San Diego, Calif 92037, USA
    Circulation 110:374-9. 2004
    ..By decreasing restenosis, drug-eluting stents may have reduced the "reintervention gap" between surgery and percutaneous intervention, making the percutaneous route preferable...
  94. ncbi request reprint Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
    David R Holmes
    Saint Mary s Hospital, Rochester, Minn, USA
    Circulation 109:634-40. 2004
    ....
  95. ncbi request reprint Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
    David J Cohen
    Harvard Clinical Research Institute, Boston, Mass, USA
    Circulation 110:508-14. 2004
    ..However, the overall cost-effectiveness of this strategy is unknown...
  96. ncbi request reprint Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients
    Mark A Grise
    Division of Cardiovascular Disease, Scripps Clinic, La Jolla, California 92037, USA
    Catheter Cardiovasc Interv 60:41-4. 2003
    ..There are few good options to treated accelerated transplant vasculopathy. Radiation therapy may be a viable option in this difficult patient population...
  97. ncbi request reprint Local application of antisense for prevention of restenosis
    Patrick L Iversen
    AVIBioPharma, Corvallis, OR, USA
    Methods Mol Med 106:37-50. 2005
  98. ncbi request reprint Cause of death with bare metal and sirolimus-eluting stents
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 27:2815-22. 2006
    ..The aim of the present study was to compare the incidence and cause of death between patients who received sirolimus-eluting or bare metal stents...
  99. ncbi request reprint Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials
    Dean J Kereiakes
    Heart Center of Greater Cincinnati and the Lindner Center for Research and Education at The Christ Hospital, Ohio Heart and Vascular Center Inc, Cincinnati, Ohio 45219, USA
    J Am Coll Cardiol 48:21-31. 2006
    ..The purpose of this research was to determine the relative safety and efficacy of multiple (> or =2) overlapping Cypher sirolimus-eluting stents (SES) (Johnson & Johnson, New Brunswick, New Jersey)...
  100. ncbi request reprint Left main drug-eluting stents: natural progression or a bridge too far?
    Gregg W Stone
    J Am Coll Cardiol 50:498-500. 2007
  101. ncbi request reprint Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses
    Erick Schampaert
    Cardiology Division, Hopital du Sacre Coeur de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 98:36-41. 2006
    ....